EUVIMEDEUVIMED entdecken
Crossref

Integrin β8 prevents pericyte-myofibroblast transition and renal fibrosis through inhibiting the TGF-β1/TGFBR1/Smad3 pathway in diabetic kidney disease

Yiling Cao, Hua Su, Jieyu Zeng, Yaru Xie, Zezhou Liu, Feng Liu, Yang Qiu, Fan Yi, Jihong Lin, Hans-Peter Hammes, Chun Zhang

Translational Research · 2024-03 · 265 · 36-50

DOI: 10.1016/j.trsl.2023.10.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Research, 2024-03. Verfasst von Yiling Cao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Nephropathies, Integrin beta Chains. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is one of the leading causes to develop end-stage kidney disease worldwide. Pericytes are implicated in the development of tissue fibrosis. However, the underlying mechanisms of pericytes in DKD remain largely unknown. We isolated and cultured primary pericytes and rat mesangial cells (HBZY-1). Western blot and qRT-PCR analysis were used to explore the role and regulatory mechanism of Integrin β8/transforming growth factor beta 1 (TGF-β1) pathway. We also constructed pericyte-specific Integrin β8 knock-in mice as the research objects to determine the role of Integrin β8 in vivo. We discovered that reduced Integrin β8 expression was closely associated with pericyte transition in DKD. Overexpressed Integrin β8 in pericytes dramatically suppressed TGF-β1/TGF beta receptor 1 (TGFBR1)/Smad3 signaling pathway and protected glomerular endothelial cells (GECs) in vitro. In vivo, pericyte-specific Integrin β8 knock-in ameliorated pericyte transition, endothelium injury and renal fibrosis in STZ-induced diabetic mice. Mechanistically, Murine double minute 2 (MDM2) was found to increase the degradation of Integrin β8 and caused TGF-β1 release and activation. Knockdown MDM2 could partly reverse the decline of Integrin β8 and suppress pericytes transition. In conclusion, the present findings suggested that upregulated MDM2 expression contributes to the degradation of Integrin β8 and activation of TGF-β1/TGFBR1/Smad3 signaling pathway, which ultimately leads to pericyte transition during DKD progression. These results indicate MDM2/Integrin β8 might be considered as therapeutic targets for DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetic NephropathiesIntegrin beta ChainsAnimalsMiceRatsEndothelial CellsFibrosisKidneyMyofibroblastsPericytesReceptor, Transforming Growth Factor-beta Type ITransforming Growth Factor beta1Smad3 Protein

Stichwörter der Autor:innen

Diabetic kidney diseaseFibrosisIntegrin β8PericyteTGF-β1

Substanzen

Integrin beta ChainsReceptor, Transforming Growth Factor-beta Type ITransforming Growth Factor beta1integrin beta8Tgfb1 protein, mouseTgfbr1 protein, mouseSmad3 protein, mouseSmad3 Protein

Autor:innen und Institutionen

  • Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, China.
  • 5th Medical Department, Medical Faculty Mannheim, University of Heidelberg, D-68167 Mannheim, Germany.
  • Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: drzhangchun@hust.edu.cn.

Förderung

  • Deutsche Forschungsgemeinschaft
  • National Natural Science Foundation of China

Zitieren

APA

Cao, Y., Su, H., Zeng, J., Xie, Y., Liu, Z., Liu, F., Qiu, Y., Yi, F., Lin, J., Hammes, H. P., & Zhang, C. (2024). Integrin β8 prevents pericyte-myofibroblast transition and renal fibrosis through inhibiting the TGF-β1/TGFBR1/Smad3 pathway in diabetic kidney disease. Translational Research, 265, 36-50. https://doi.org/10.1016/j.trsl.2023.10.007

Vancouver

Cao Y, Su H, Zeng J, Xie Y, Liu Z, Liu F, et al. Integrin β8 prevents pericyte-myofibroblast transition and renal fibrosis through inhibiting the TGF-β1/TGFBR1/Smad3 pathway in diabetic kidney disease. Translational Research. 2024;265:36-50. doi:10.1016/j.trsl.2023.10.007

BibTeX
@article{Cao2024,
  author = {Cao, Yiling and Su, Hua and Zeng, Jieyu and Xie, Yaru and Liu, Zezhou and Liu, Feng and Qiu, Yang and Yi, Fan and Lin, Jihong and Hammes, Hans-Peter and Zhang, Chun},
  title = {Integrin β8 prevents pericyte-myofibroblast transition and renal fibrosis through inhibiting the TGF-β1/TGFBR1/Smad3 pathway in diabetic kidney disease},
  journal = {Translational Research},
  year = {2024},
  volume = {265},
  pages = {36--50},
  doi = {10.1016/j.trsl.2023.10.007}
}
Kostenlos starten →